If you liked this article you might like

Agios Shares Spike on Planned Drug Application
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
Agios Pharmaceuticals (AGIO) Highlighted As Weak On High Volume
Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact